Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy

Transplantation Proceedings

Volumn 45, Issue 10, 2013, Pages 3665-3667

  Calderon Cabrera C ^a   Marquez Malaver F J ^a   De La Cruz Vicente, F ^a   Falantes, F ^a   Carrillo, E ^a   Parody, R ^a   Montero, I ^a   Gonzalez Campos J ^a   Martino, M L ^a   Carmona, M ^a   Perez Simon J A ^a   Espigado, I ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ALLOGRAFT; ARTICLE; BLEEDING; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CHILD; DISEASE FREE SURVIVAL; EVENT FREE SURVIVAL; FEMALE; FOLLICULAR LYMPHOMA; FOLLOW UP; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIGH RISK PATIENT; HODGKIN DISEASE; HUMAN; INFECTION; LARGE CELL LYMPHOMA; LONG TERM SURVIVAL; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MANTLE CELL LYMPHOMA; MEDICAL RECORD REVIEW; MORTALITY; MYELOABLATIVE CONDITIONING; NONRELAPSE MORTALITY; OVERALL SURVIVAL; PRIORITY JOURNAL; RELAPSE; REMISSION; SALVAGE THERAPY; SCHOOL CHILD; T CELL LYMPHOMA;

ADOLESCENT; ADULT; CHILD; COMMUNICABLE DISEASES; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LYMPHOMA; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RISK FACTORS; SALVAGE THERAPY; TERTIARY CARE CENTERS; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890108508     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2013.11.007     Document Type: Article

References (4)

1. A. Greb, J. Bohlius, and D. Schiefer High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive non-Hodgkin lymphoma (NHL) in adults Cochrane Database Syst Rev 1 2008 CD004024
2. C. Haioun, E. Lepage, and C. Gisselbrecht Groupe d'Etude des Lymphomes de l'Adulte. Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2 J Clin Oncol 15 1997 113
3. T. Philip, C. Guglielmi, and A. Hagenbeek Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma N Engl J Med 333 1995 1540
4. P.J. Stiff, J.M. Unger, and J. Cook Randomized phase III US/Canadian intergroup trial (SWOG S9704) comparing CHOP ± R for eight cycles to CHOP ± R for six cycles followed by autotransplant for patients with high-intermediate (H-Int) or high IPI grade diffuse aggressive non-Hodgkin lymphoma (NHL) (abstract 8001) J Clin Oncol 2011 29